2,003
Views
11
CrossRef citations to date
0
Altmetric
Research Paper

Long non-coding RNA LUCAT1 inhibits myocardial oxidative stress and apoptosis after myocardial infarction via targeting microRNA-181a-5p

, , & ORCID Icon
Pages 4546-4555 | Received 24 May 2021, Accepted 05 Aug 2021, Published online: 20 Aug 2021

References

  • Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet. 2017 Jan 14;389(10065):197–210.
  • Zhang L, Zhang J, Su S, et al. Changes in interleukin-27 levels in patients with acute coronary syndrome and their clinical significance. PeerJ. 2019;7:e5652.
  • Li L, Dai W, Li W, et al. Integrated network pharmacology and metabonomics to reveal the myocardial protection effect of Huang-Lian-Jie-Du-Tang on myocardial ischemia. Front Pharmacol. 2020;11:589175.
  • Yuan WF, Zhao XX, Sun WJ, et al. LGE-MRI in the assessment of left-ventricular remodelling in myocarditis. Curr Med Imaging Rev. 2019;15(9):900–905.
  • Tong J, Yu Q, Li C, et al. Successful revascularization of noninfarct related artery with chronic total occlusion among acute myocardial infarction patients: a systematic review and meta-analysis. Medicine (Baltimore). 2018 Jan;97(3):e9655.
  • Büttner P, Obradovic D, Wunderlich S, et al. Selenoprotein P in myocardial infarction with cardiogenic shock. Shock. 2020 Jan;53(1):58–62.
  • Cai B, Li Z, Ma M, et al. Long noncoding RNA SMUL suppresses SMURF2 production-mediated muscle atrophy via nonsense-mediated mRNA decay. Mol Ther Nucleic Acids. 2021 Mar 5;23:512–526.
  • Shi HJ, Wang MW, Sun JT, et al. A novel long noncoding RNA FAF inhibits apoptosis via upregulating FGF9 through PI3K/AKT signaling pathway in ischemia-hypoxia cardiomyocytes. J Cell Physiol. 2019 Dec;234(12):21973–21987.
  • Zhuo LA, Wen YT, Wang Y, et al. LncRNA SNHG8 is identified as a key regulator of acute myocardial infarction by RNA-seq analysis. Lipids Health Dis. 2019 Nov 18;18(1):201.
  • Liu K, Zhao D, Wang D. LINC00528 regulates myocardial infarction by targeting the miR-143-3p/COX-2 axis. Bioengineered. 2020 Dec;11(1):11–18.
  • Sun Y, Hu ZQ. LncRNA HOTAIR aggravates myocardial ischemia-reperfusion injury by sponging microRNA-126 to upregulate SRSF1. Eur Rev Med Pharmacol Sci. 2020 Sep;24(17):9046–9054.
  • Lv J, Zhu Y, Yao S. LncRNAMORT is upregulated in myocardial infarction and promotes the apoptosis of cardiomyocyte by downregulating miR-93. BMC Cardiovasc Disord. 2020 May 25;20(1):247.
  • Yin Y, Yang ZF, Li XH, et al. Knockdown of long non-coding RNA LUCAT1 reverses high glucose-induced cardiomyocyte injury via targeting CYP11B2. Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8560–8565.
  • Li T, Qian D, Guoyan J, et al. Downregulated long noncoding RNA LUCAT1 inhibited proliferation and promoted apoptosis of cardiomyocyte via miR-612/HOXA13 pathway in chronic heart failure. Eur Rev Med Pharmacol Sci. 2020 Jan;24(1):385–395.
  • Wang J, Pan Y, Dai F, et al. Serum miR-195-5p is upregulated in gestational diabetes mellitus. J Clin Lab Anal. 2020 Aug;34(8):e23325.
  • Yang B, Dong R, Zhao H. Inhibition of microRNA-346 inhibits myocardial inflammation and apoptosis after myocardial infarction via targeting NFIB. Eur Rev Med Pharmacol Sci. 2020 Nov;24(22):11752–11760.
  • Zou JF, Wu XN, Shi RH, et al. Inhibition of microRNA-184 reduces H2O2-mediated cardiomyocyte injury via targeting FBXO28. Eur Rev Med Pharmacol Sci. 2020 Nov;24(21):11251–11258.
  • Li J, Yuan YQ, Zhang L, et al. Exogenous hydrogen sulfide protects against high glucose-induced apoptosis and oxidative stress by inhibiting the STAT3/HIF-1α pathway in H9c2 cardiomyocytes. Exp Ther Med. 2019 Nov;18(5):3948–3958.
  • Wen Z, Mai Z, Zhu X, et al. Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN/AKT pathway. Stem Cell Res Ther. 2020 Jan 23;11(1):36.
  • Pickell Z, Williams AM, Alam HB, et al. Histone deacetylase inhibitors: a novel strategy for neuroprotection and cardioprotection following ischemia/reperfusion injury. J Am Heart Assoc. 2020 Jun 2;9(11):e016349.
  • Hu S, Wang H, Zhu J, et al. Effect of intra-coronary administration of tirofiban through aspiration catheter on patients over 60 years with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Medicine (Baltimore). 2018 May;97(21):e10850.
  • Bredemeier M, Lopes LM, Eisenreich MA, et al. Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc Disord. 2018 Feb 7;18(1):24.
  • Zhu B, Yang J, Chen S, et al. Oxymatrine on Hsp90a expression and apoptosis in a model of lung ischemia-reperfusion injury. Exp Ther Med. 2017 Apr;13(4):1381–1385.
  • Li CX, Song J, Li X, et al. Circular RNA 0001273 in exosomes derived from human umbilical cord mesenchymal stem cells (UMSCs) in myocardial infarction. Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):10086–10095.
  • Pan JX. LncRNA H19 promotes atherosclerosis by regulating MAPK and NF-kB signaling pathway. Eur Rev Med Pharmacol Sci. 2017 Jan;21(2):322–328.
  • Liu ZF, Hu WW, Li R, et al. Expression of lncRNA-ANRIL in patients with coronary heart disease before and after treatment and its short-term prognosis predictive value. Eur Rev Med Pharmacol Sci. 2020 Jan;24(1):376–384.
  • Sun Y, Jin SD, Zhu Q, et al. Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression. Oncotarget. 2017 Apr 25;8(17):28297–28311.
  • Gramantieri L, Baglioni M, Fornari F, et al. LncRNAs as novel players in hepatocellular carcinoma recurrence. Oncotarget. 2018 Oct 12;9(80):35085–35099.
  • Dong X, Dong X, Gao F, et al. Non-coding RNAs in cardiomyocyte proliferation and cardiac regeneration: dissecting their therapeutic values. J Cell Mol Med. 2021 Mar;25(5):2315–2332.
  • Scicluna BP, Uhel F, van Vught LA, et al. The leukocyte non-coding RNA landscape in critically ill patients with sepsis. eLife. 2020 Dec 11;9. DOI:10.7554/eLife.58597
  • Nai Y, Pan C, Hu X, et al. LncRNA LUCAT1 contributes to cell proliferation and migration in human pancreatic ductal adenocarcinoma via sponging miR-539. Cancer Med. 2020 Jan;9(2):757–767.
  • Xia Q, Zhang L, Yan H, et al. LUCAT1 contributes to MYRF-dependent smooth muscle cell apoptosis and may facilitate aneurysm formation via the sequestration of miR-199a-5p. Cell Biol Int. 2020 Mar;44(3):755–763.
  • Liu HY, Yu LF, Zhou TG, et al. Lipopolysaccharide-stimulated bone marrow mesenchymal stem cells-derived exosomes inhibit H2O2-induced cardiomyocyte inflammation and oxidative stress via regulating miR-181a-5p/ATF2 axis. Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):10069–10077.
  • Liu Y, Cheng T, Du Y, et al. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15. BMC molecular and cell biology. 2020 Sep 30;21(1):69.
  • Constanso-Conde I, Hermida-Prieto M, Barge-Caballero E, et al. Circulating miR-181a-5p as a new biomarker for acute cellular rejection in heart transplantation. The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation. 2020 Oct;39(10):1100–1108.
  • Cheng Y, Li J, Wang C, et al. Inhibition of long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 attenuates high glucose-induced cardiomyocyte apoptosis via regulation of miR-181a-5p. Exp Anim. 2020 Jan 29;69(1):34–44.